lekoptin has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eberlein, W; Heider, J; Kobinger, W; Lillie, C; Luger, P; Müller, P; Noll, K; Psiorz, M; Reiffen, M | 1 |
1 other study(ies) available for lekoptin and Coronary Disease
| Article | Year |
|---|---|
Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Chemical Phenomena; Chemistry; Coronary Disease; Guinea Pigs; Heart Rate; Isoindoles; Molecular Conformation; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Phthalimides; Rabbits; Rats; Structure-Activity Relationship; Verapamil | 1990 |